肌少症患者肌肉质量测评工具的研究进展
Research progress of muscle quality measurement tools for sarcopenia patients
  
DOI:10.3969/j.issn.1006-7108.2023.01.025
中文关键词:  肌少症  肌肉质量  测评工具  研究进展
英文关键词:sarcopenia  skeletal muscle mass  measurement tools  research progress
基金项目:中华护理学会科研项目(ZHKY201910);贵州省卫生健康委员会科学技术基金(gzwkj2021-476)
作者单位
唐欢1 李娟2* 余欢2 唐泽丽1 陈作秀3 郝明青3 1.遵义医科大学贵州 遵义 563003 2.贵州省人民医院贵州 贵阳 550001 3.贵州中医药大学贵州 贵阳 550002 
摘要点击次数: 393
全文下载次数: 0
中文摘要:
      肌少症是肌肉质量和肌肉强度呈渐进性减少和下降的衰老综合征,可导致跌倒、骨折和失能等风险增高,对患者机体功能造成严重影响,极大降低了患者的生活质量,甚至导致死亡。为提高肌少症诊断和治疗效果,选择科学有效的测评工具十分重要。目前,各国际组织对肌少症的诊断标准仍未达成统一共识,尤其在肌肉质量测定部分存在较多争议。本文旨在通过复习总结相关国内外文献,阐述肌少症的筛查流程、诊断标准,重点探讨肌肉质量的测评工具及其优势与不足,以期为肌肉质量测评工具的选择及准确评估提供借鉴。
英文摘要:
      Sarcopenia refers to the aging symptom complex with gradual reduction and decline of skeletal muscle mass and strength, which can increase potential falls, fractures and disability, cause serious effects on the function of the patient's body, and greatly reduce the patient's quality of life, even generate poor health outcomes, for instance, death. In order to improve the diagnosis and treatment of sarcopenia, it is vital to select scientific and effective assessment tools. At present, international organizations have not reached a consensus on the diagnostic criteria of sarcopenia, especially in the determination of muscle mass. This paper aims to review and summarize the relevant domestic and international literature, describe the screening process and diagnostic criteria of sarcopenia, focus on muscle mass measurement tools and their advantages and shortcomings, offer reference for the choice and accurate measurement of muscle mass assessment tools.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=FC9DA7BF2F842A3BAE24B54F70914FE6036E673388772411081D9C782013BEB417AC2D4CF119A8A8D623737F6F936A65789CF4F0077DDE1047BEFABFA0EBA408A200CC71DBAB91401A5AC6738196DB42&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=527A01A248DACB72&jid=CA678592D11E309E8E3FB3B2BFE9BE1A&yid=BA1E75DF0B7E0EB2&aid=F7D0025B820CBB4B4C389D85089C1E3F&vid=&iid=CA4FD0336C81A37A&sid=28F8B56DB6BEE30E&eid=76B5E24D6EC46B4B&fileno=202301025&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="527A01A248DACB72"; var my_jid="CA678592D11E309E8E3FB3B2BFE9BE1A"; var my_yid="BA1E75DF0B7E0EB2"; var my_aid="F7D0025B820CBB4B4C389D85089C1E3F";